13925-522 : Pentamidine Isethionate 300 mg/300mg Respiratory (Inhalation) Inhalant
NDC: | 13925-522 |
Labeler: | Seton Pharmaceuticals |
Product Type: | Human Prescription Drug |
Drug Name: | Pentamidine Isethionate |
Dosage Form: | Respiratory (Inhalation) Inhalant |
Application #: | ANDA206667 |
Rev. Date: |
NDC Package Codes:
- 13925-522-01: 1 VIAL IN 1 CARTON (13925‑522‑01) > 300 MG IN 1 VIAL
Active Ingredients:
- Pentamidine Isethionate
Dosage Strength:
- 300 mg/300mg
Pharmaceutical Classes:
- Antiprotozoal [EPC]
Related Products:
Based on records with the same trade name.- 13925-515 Pentamidine Isethionate 300 mg/300mg Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Seton Pharmaceuticals
- 23155-748 Pentamidine Isethionate 300 mg/300mg Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.
- 39822-3030 Pentamidine Isethionate 300 mg/6ml Respiratory (Inhalation) Inhalant by Xgen Pharmaceuticals Djb, Inc.
- 39822-3050 Pentamidine Isethionate 300 mg/3ml Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Xgen Pharmaceuticals Djb, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 13925-515Next: 13925-523 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.